QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma 期刊论文 2017, 卷号: 32, 期号: 1, 页码: 221-228 作者:  Chan Anthony W H;  Chong Charing C N;  Mo Frankie K F;  Wong John;  Yeo Winnie 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04 Cancer of the Liver Italian Program (CLIP)  Child-Pugh  albumin  bilirubin  liver function  prognosis  survival  tumor staging   Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma 期刊论文 2016, 卷号: 31, 期号: 10, 页码: 1766-1772 作者:  Chan Anthony W H;  Chong Charing C N;  Mo Frankie K F;  Wong John;  Yeo Winnie 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Barcelona Clinic Liver Cancer (BCLC)  liver neoplasm  staging  survival   The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/beta-catenin signaling and is frequently silenced in multiple tumors. 期刊论文 PLOS ONE, 2011, 卷号: 6, 期号: 11, 页码: e27346 作者:  Shu, Xing-sheng*;  Geng, Hua;  Li, Lili;  Ying, Jianming;  Ma, Chunhong 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03 DNA methylation,Epigenetics,Methylation,Cellular stress responses,Oncogenes,Polymerase chain reaction,Carcinomas,Oncogenic signaling   The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/beta-Catenin Signaling and Is Frequently Silenced in Multiple Tumors 期刊论文 PLOS ONE, 2011, 卷号: 6, 期号: 11 作者:  Shu, Xing-sheng;  Geng, Hua;  Li, Lili;  Ying, Jianming;  Ma, Chunhong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/23 Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients 期刊论文 2011, 卷号: 30, 期号: 5, 页码: 327-35 作者:  Xu Bing-He;  Jiang Ze-Fei;  Chua Daniel;  Shao Zhi-Min;  Luo Rong-Cheng 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Lapatinib  capecitabine  HER2  metastatic breast cancer   Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma 期刊论文 BMC CANCER, 2010, 卷号: 10 作者:  Yeo, Winnie;  Chen, Pei-Jer;  Furuse, Junji;  Han, Kwang-Hyub;  Hsu, Chiun 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19 Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion 期刊论文 LIVER INTERNATIONAL, 2010, 卷号: 30, 期号: 10 作者:  Chen, Pei-Jer;  Furuse, Junji;  Han, Kwang-Hyub;  Hsu, Chiun;  Lim, Ho-Yeong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 antineoplastic agents  Asia  clinical practice patterns  clinical trials  hepatocellular carcinoma  liver neoplasms